BNBX vs EW · P/E 0.0, rev $2.2M vs P/E 47, rev $3.39B
Applied DNA Sciences, Inc. (BNBX) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Applied DNA Sciences, Inc. (BNBX) is a asset management company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported BNBX revenue for 2026-06-30 was $2.2M. Net income was -$29.9M. Revenue was up 38.1% from 2026-03-31 to 2026-06-30. BNBX currently screens at market cap $3.3M and trailing P/E 0.0.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
BNBX currently screens at market cap $3.3M and trailing P/E 0.0. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the BNBX and EW stock pages for the full models.
Not investment advice.